UK's increasing obesity surgery rates still far short of demand
This article was originally published in Clinica
Executive Summary
Despite a significant rise in obesity surgery cases in the UK over the last decade, current access to the procedure still falls far short of demand, according to Healthier Weight, a leading UK provider in this area of healthcare. Weight-loss procedures in the NHS rose from 238 in 2000 to over 2,500 in 2007, totalling almost 7,000 operations between April 2000 and March 2008, the British Medical Journal (BMJ) reported last week.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.